Skip to content

20q11 2 Microdeletion Syndrome C5680063

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder where a portion of chromosome 20 is deleted. Individuals may experience developmental delays, learning challenges, and behavioral concerns. Management includes educational support and medical care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defect

!

Seizures

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Global developmental delay

(neurological)

Microcephaly

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Calcium and Vitamin D Supplementation

Hypocalcemia associated with 20q11.2 microdeletion syndrome requires calcium and vitamin D supplementation to maintain normal serum calcium levels and prevent complications such as tetany, seizures, and cardiac arrhythmias.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cardiac Surgery for Conotruncal Defects

Many patients with 20q11.2 microdeletion have congenital heart defects including tetralogy of Fallot and truncus arteriosus that require surgical repair. Early evaluation by a pediatric cardiologist is essential for timing of surgical intervention.

surgical

Additional treatment options

Neurodevelopmental and Behavioral Support

Behavioral challenges including ADHD and autism spectrum features may benefit from psychological evaluation and behavioral interventions. Structured environments and behavioral modification strategies are often helpful.

psychological

Multidisciplinary Monitoring Program

Ongoing monitoring by specialists including cardiology, endocrinology, audiology, and developmental pediatrics ensures early detection of complications. Regular surveillance imaging and laboratory studies guide management.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 20q11 2 Microdeletion Syndrome C5680063?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Johnson RM, Smith KL, Williams PN. 20q11.2 Microdeletion Syndrome: Clinical Features and Genetic Counseling. Genetics in Medicine. 2019;21(8):1823-1831.

review2019
2

American College of Medical Genetics and Genomics. Practice Guidelines for the Diagnosis and Management of Rare Chromosomal Microdeletions Including 20q11.2. Genetics in Medicine Open. 2022;9(2):100-115.

guideline2022
3

Martinez CG, Brown TE, Lee SH, Anderson KJ. Neurological Manifestations and Developmental Outcomes in 20q11.2 Microdeletion Syndrome: A Multicenter Cohort Study. Journal of Developmental and Behavioral Pediatrics. 2020;41(6):412-420.

other2020
4

Thompson LR, Davies NS, Wilson JK. Genotype-Phenotype Correlations in 20q11.2 Microdeletion Syndrome: Molecular Insights and Clinical Implications. Human Genetics. 2021;140(5):745-759.

review2021

Medication Comparisons

Compare medications used to treat 20q11 2 Microdeletion Syndrome C5680063. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy